These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 7694266

  • 21. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM, Hay N, Liao S.
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [Abstract] [Full Text] [Related]

  • 22. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.
    Zhao XY, Boyle B, Krishnan AV, Navone NM, Peehl DM, Feldman D.
    J Urol; 1999 Dec; 162(6):2192-9. PubMed ID: 10569618
    [Abstract] [Full Text] [Related]

  • 23. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 24. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.
    Henttu P, Liao SS, Vihko P.
    Endocrinology; 1992 Feb; 130(2):766-72. PubMed ID: 1370795
    [Abstract] [Full Text] [Related]

  • 25. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
    Ripple MO, Henry WF, Rago RP, Wilding G.
    J Natl Cancer Inst; 1997 Jan 01; 89(1):40-8. PubMed ID: 8978405
    [Abstract] [Full Text] [Related]

  • 26. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.
    Schuurmans AL, Bolt J, Veldscholte J, Mulder E.
    J Steroid Biochem Mol Biol; 1991 Jan 01; 40(1-3):193-7. PubMed ID: 1958520
    [Abstract] [Full Text] [Related]

  • 27. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C, Hum DW, Bélanger A.
    Endocrinology; 1996 Jul 01; 137(7):2872-9. PubMed ID: 8770908
    [Abstract] [Full Text] [Related]

  • 28. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV, Esquenet M, Heyns W, Rombauts W, Verhoeven G.
    Mol Cell Endocrinol; 1994 Sep 01; 104(2):153-62. PubMed ID: 7527352
    [Abstract] [Full Text] [Related]

  • 29. Regulation of growth, PSA/PAP and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells.
    Hsieh TY, Ng CY, Mallouh C, Tazaki H, Wu JM.
    Biochem Biophys Res Commun; 1996 Jun 05; 223(1):141-6. PubMed ID: 8660360
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
    Henttu P, Vihko P.
    Cancer Res; 1993 Mar 01; 53(5):1051-8. PubMed ID: 7679946
    [Abstract] [Full Text] [Related]

  • 32. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
    Presnell SC, Borchert KM, Glover WJ, Gregory CW, Mohler JL, Smith GJ.
    Carcinogenesis; 1998 Apr 01; 19(4):585-90. PubMed ID: 9600341
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
    Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ.
    Prostate; 1992 Apr 01; 21(1):63-73. PubMed ID: 1379363
    [Abstract] [Full Text] [Related]

  • 35. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK, Grootegoed JA, Blok LJ.
    Endocr Relat Cancer; 2005 Mar 01; 12(1):135-48. PubMed ID: 15788645
    [Abstract] [Full Text] [Related]

  • 36. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J.
    Mol Endocrinol; 1997 Feb 01; 11(2):148-61. PubMed ID: 9013762
    [Abstract] [Full Text] [Related]

  • 37. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
    Lu S, Tsai SY, Tsai MJ.
    Endocrinology; 1999 Nov 01; 140(11):5054-9. PubMed ID: 10537131
    [Abstract] [Full Text] [Related]

  • 38. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G.
    Cancer Res; 1997 Mar 15; 57(6):1086-90. PubMed ID: 9067276
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.